Hormone replacement therapy and a risk for breast cancer in postmenopausal women: analysis of some epidemiological studies

V N Konovalova , V P Smetnik , V N Konovalova , V P Smetnik

Russian Journal of Oncology ›› 2011, Vol. 16 ›› Issue (2) : 53 -56.

PDF
Russian Journal of Oncology ›› 2011, Vol. 16 ›› Issue (2) : 53 -56. DOI: 10.17816/onco39885
Articles
other

Hormone replacement therapy and a risk for breast cancer in postmenopausal women: analysis of some epidemiological studies

Author information +
History +
PDF

Abstract

The paper provides an epidemiological update on a risk for breast cancer during menopausal hormone replacement therapy. It gives the results of large observational and randomized clinical trials, as well as the point of view of the International Menopause Society in the context of evidence-based medicine.

Keywords

hormone replacement therapy / breast cancer / postmenopause

Cite this article

Download citation ▾
V N Konovalova, V P Smetnik, V N Konovalova, V P Smetnik. Hormone replacement therapy and a risk for breast cancer in postmenopausal women: analysis of some epidemiological studies. Russian Journal of Oncology, 2011, 16(2): 53-56 DOI:10.17816/onco39885

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

American Cancer Society. Breast cancer facts and figures 2003-2004. http://www.cancer.org/downloads/STT/ CAFF2003BrFPWSecured.pdg.

[2]

Black W. C., Welch H. G. // N. Engl. J. Med. - 1993. - Vol. 328. - P. 1237-1243.

[3]

Chen C. L. et al. // J. A. M. A. - 2002. - Vol. 287. - P. 734- 741.

[4]

Chlebowski R. T. et al. // J. A. M. A. - 2003. - Vol. 289. - P. 3243-3253.

[5]

Colditz G. A. et al. // N. Engl. J. Med. - 1995. - Vol. 330. - P. 1589-1599.

[6]

Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer // Lancet. - 1997. - Vol. 350. - P. 1047-1059.

[7]

Darmasetiawan M. S. // Menopause Dig. - 2004. - Vol. 16, N 5. - P. 5-8.

[8]

Foidart J. M. et al. // Climacteric. - 2007. - Vol. 10, N 2. - P. 54-61.

[9]

Fournier A. et al. // Int. J. Cancer. - 2005. - Vol. 114, N 3. - P. 448-454.

[10]

Fournier A. et al. // Breast Cancer Res. Treat. - 2008. - Vol. 107, N 1. - P. 103-111.

[11]

Garland M. et al. // Am. J. Epidemiol. - 1998. - Vol. 147, N 7. - P. 636-643.

[12]

Heikkinen J., Vaheri R., Timonen U. // J. Br. Menopause Soc. - 2006. - Vol. 12, N 3. - P. 115-125.

[13]

Hulley S. et al. // J. A. M. A. - 1998. - Vol. 280. - P. 605- 613.

[14]

Kenemans P., van der Mooren J. // Gynaecol. Forum. - 2004. - Vol. 9, N 3. - P. 15-17.

[15]

Key T. J. et al. // Lancet Oncol. - 2001. - Vol. 2. - P. 133- 140.

[16]

Magnusson C. et al. // Cancer Causes Control. - 1998. - Vol. 9, N 3. - P. 259-267.

[17]

Million Women Study Collaborators. Breast cancer and hormone replacement therapy in the Million Women Study // Lancet. - 2003. - Vol. 362. - P. 419-427.

[18]

Newcomb P. A. et al. // Cancer Epidemiol. Biomarker. Prev. - 2002. - Vol. 11. - P. 593-600.

[19]

Olsson H. L. et al. // Cancer. - 2003. - Vol. 97. - P. 1387- 1392.

[20]

Pines A. et al. International Menopause Society. // Summary of the First IMS Global Summit on menopause-related issues. - March 29-30, 2008.

[21]

Porch J. V. et al. // Cancer Causes Control. - 2002. - Vol. 13. - P. 847-854.

[22]

Ross R. K. et al. // J. Natl. Cancer. Inst. - 2000. - Vol. 92. - P. 328-332.

[23]

Shapiro S. // Climacteric Medicine - where do we go? / Eds H. P. G. Schneider, T. Naftolin. - London; New York, 2005. - P. 166-174.

[24]

Sitruk-Ware R. // Menopause. - 2002. - Vol. 9. - P. 6-15.

[25]

Vogel V. G. // Menopause. - 2008. - Vol. 15, N 4. - P. 782- 789.

[26]

Weiss L. K. et al. // Obstet. and Gynecol. - 2002. - Vol. 100. - P. 1148-1158.

[27]

Wysowski D. K. et al. // Obstet. and Gynecol. - 1995. - Vol. 85, N 1. - P. 6-10.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

142

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/